Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2024
Companies covered: 15
Tables & Figures: 134
Countries covered: 19
Pages: 138
Download Free PDF

Lacrimal Devices Market
Get a free sample of this reportGet a free sample of this report Lacrimal Devices Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Lacrimal Devices Market Size
The global lacrimal devices market was valued at USD 160.2 million in 2024 and is expected to exhibit growth at a CAGR of 4.2% from 2025 to 2034. Due to increasing technological advancements in healthcare systems and rising cases of eye illnesses, the market is witnessing remarkable growth.
Surging cases of dry eye syndrome, often linked to overuse of digital screens, environmental pollution, and global aging also add to the growth of the market. Modern lacrimal devices, such as punctal plugs and stents which provide effective relief, are in great demand which in turn is propelling the market growth positively.
Furthermore, emerging nations have been experiencing better healthcare as well as awareness towards eye care, thus creating wider scope of the lacrimal device market. Providing better patient and procedural outcomes, new innovations including smart diagnostic tools and minimally invasive surgical instruments are also fostering the market growth. Moreover, government initiatives and policies focusing on research development in ophthalmic care and eyecare also aids in the growth of lacrimal devices market.
Strong focus on patient-centered approaches from lacrimal device manufacturers fuels the market growth positively. Growing emphasis on personalized medicine makes the devices safer by improving biocompatibility, further supporting the trend. Besides, faster development of product and methodology owing to collaboration among healthcare providers and other industry & research stakeholders contributes to market expansion.
Lacrimal devices are medical instruments designed to diagnose, treat, and manage disorders of the tear drainage system, including conditions tear duct obstruction, such as dry eye syndrome, and excessive tearing. These instruments include punctal plugs, stents, syringes, and probes, that help in restoring normal tear function and maintain overall eye health.
Lacrimal Devices Market Trends
Impact of Tariff on the Market
By imposing tariffs, the import of medical devices has become more complex and costly. Additionally, the expenses in sourcing raw materials, parts, equipment, and the finished product, tariffs can greatly affect the market on lacrimal devices by making this more expensive. For instance, the devices used for the treatment of tear drainage disorders are extremely sophisticated. They incorporate advanced technologies as well as specialized materials that are not available locally. Thus, these manufacturers are highly reliant on global supply chains which makes them extremely susceptible to trade barriers such as tariffs.
When tariffs are imposed on medical imports such as medical grade polymers, surgical instruments, or electronic lenses used in precision devices, it drives up costs across the entire production chain. Hence the cost of almost the entire production chain increases. This raises the price of lacrimal implants or drainage systems for both patients and providers.
Tariffs can significantly reduce demand for lacrimal devices in price-sensitive regions by making them unaffordable. Lack of order, or erratic tariff systems, makes international investment unfavorable. It limits mid and small sized traders the most. Closed borders lead to expensive markets, disturbed supply chains, restricted medical technology access, and aid open regions become more favorable for investment and production. Even though tariffs might stimulate economic growth in domestic manufacturing over a long time period, their short run impact is adverse for the growth of the market considering the increase in costs along with the minimal growth.
Lacrimal Devices Market Analysis
Based on product, the market is segmented into stents, intubation sets, punctal plugs, tubes, cannula and spatula, dilator, and other products. The stents segment is expected to expand at a CAGR of 4.6%, reaching over USD 67.9 million by 2034. Also, the global market was valued at USD 160.2 million in 2024.
Based on application, the lacrimal devices market is classified into dry eye, glaucoma, drainage obstruction, epiphora, lacrimal gland inflammation, and other application. The dry eye segment held 40.1% share of the market in 2024, driven by several key factors.
Based on material, the lacrimal devices market is segmented into silicone, stainless steel, and other materials. The silicone segment was valued at USD 73.2 million in 2024 and is expected to grow at a 4.7% CAGR between 2025 and 2034.
Based on end use, the lacrimal devices market is segmented into hospitals, ophthalmic clincs, diagnostic centers, and other end users. The hospitals segment dominated the market with a revenue share of 46.5% in 2024 and is anticipated to reach USD 112.4 million by 2034.
In North America region, U.S. lacrimal devices market was valued at USD 53.5 million in 2024 and is projected to grow substantially in the coming years.
In the Europe lacrimal devices market, the UK is projected to grow remarkably in the coming years.
China holds a dominant position in the Asia Pacific lacrimal devices market.
Brazil holds a dominant position in the Latin America lacrimal devices market.
Lacrimal Devices Market Share
The market features key players like Aurolab, B. Braun, Bess Medical, Braintree, and others. The top 3 players accounted for around 60% share in the market. Along with the industry leaders the market is undergoing technological and materials innovations. New inventions, such as drug-eluting stents, implementation of less invasive surgical procedures, and the use of biocompatible implants are increasingly improving the patients results and recovery periods. Greater understanding and awareness of ophthalmic issues along with the surging aged population are augmenting the demand across markets.
The Asia-Pacific and Latin America regions are expected to experience strong growth due to developments in healthcare systems and increased availability of eye care services. Companies are also strategically pursuing collaborations or mergers to enhance their geographic presence and product offerings which alters the competitive environment. In addition, outpatient focused regulatory approvals for new devices are creating streamlined treatment pathways while lowering expenses. From a market perspective, these changes point towards overcoming cost-related hurdles while expanding in the lacrimal devices segment which has previously been considered more sophisticated.
Lacrimal Devices Market Companies
Prominent players operating in the lacrimal devices industry include:
Lacrimal Devices Industry News:
The lacrimal devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Application
Market, By Material
Market, By End Use
The above information is provided for the following regions and countries: